Direktorat Registrasi ObatValid

ATORVASTATIN CALCIUM TRIHYDRATE

BPOM Number: GKL2043501317A1
Approved: 13 August 2025
Expiry: 7 August 2030
Form: TABLET SALUT SELAPUT

About This Registration

ATORVASTATIN CALCIUM TRIHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2043501317A1. Its current registration status is Valid, with the licence valid until 7 August 2030. The product is registered to AMAROX PHARMA GLOBAL - INDONESIA. BPOM first approved this registration in August 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 9 STRIP @ 10 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

AMAROX PHARMA GLOBAL - INDONESIA
KAB. BEKASI
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

AMAROX PHARMA GLOBAL - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (1)

ATORVASTATIN CALCIUM TRIHYDRATE

Market Intelligence

Owner Portfolio: AMAROX PHARMA GLOBAL - INDONESIA holds 240 BPOM registrations
Manufacturer Scale: AMAROX PHARMA GLOBAL - INDONESIA produces 240 registered products
Registration Age: Registered for 1 year, 1 month

FDA Cross-Reference

via openFDA

Generic Name: ATORVASTATIN CALCIUM
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?